Insilico Medicine Names UAE’s First AI Discovered Preclinical Drug Candidate

Apr 28, 2026
Insilico Medicine has announced ISM0387, the first preclinical drug candidate discovered in the UAE using generative AI, developed in collaboration with the Emirates Drug Establishment and supported by Abu Dhabi institutions.
Insilico Medicine Names UAE’s First AI Discovered Preclinical Drug Candidate

Insilico Medicine has nominated ISM0387, the first preclinical drug candidate discovered in the United Arab Emirates using generative AI, announced in a press release. The nomination was made in partnership with the Emirates Drug Establishment and supported by the Abu Dhabi Investment Office and the Department of Health Abu Dhabi.

ISM0387 is an MTA cooperative PRMT5 inhibitor designed to target glioblastoma. It features a novel structure with improved in vitro activity, selectivity, and brain penetration properties. The compound was discovered locally through Insilico’s Pharma.AI and Chemistry42 platforms, which screened 90 AI generated candidates and completed the lead discovery phase in six months.

The project began in May 2025 as a pilot program to demonstrate that generative AI could shorten drug discovery timelines. The UAE-based team completed the full discovery and optimization process within a year, marking Insilico’s 30th AI supported preclinical candidate overall.

The discovery took place at Insilico’s research and development center in Masdar City, established in partnership with the Abu Dhabi Investment Office. The center employs around 40 specialists working on AI enhanced drug design and local pharmaceutical innovation.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Guide
Specialist Ambient Medical Scribe Vendors

Specialist Ambient Medical Scribe Vendors

AI scribes that turn medical consultations into draft clinical notes

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.